Ashok Kumar Yadav
Panjab University, CBMR Lucknow, UPTU, Lucknow University, University of Leipzig
0000-0003-0639-8702
About
Dr. Ashok Kumar Yadav, is working as UGC Assistant Professor at University Insstitute of pharmaceutical Sciences, Panjab University, Chandigarh. He obtained his B. Sc. (1997) and M. Sc. (Chemistry, 1999) from Lucknow University. In 2002, he started his Ph. D. in Synthetic Organic Chemistry with Prof. H. Ila at the Department of Chemistry, Indian Institute of Technology, Kanpur, India. Registration for Ph. D. Degree was in UPTU. After finishing Ph. D., he joined the group of Prof. Manas K. Ghorai at the Department of Chemistry, Indian Institute of Technology, Kanpur, India as CSIR RA. In 2010, he moved to the Organic Synthesis Research Laboratory, University of Antwerp, Belgium, where he had worked with Prof. Bert Maes. Further, in 2012, he joined the group of Prof. Christoph Schneider at Institut für Organische Chemie, Universität Leipzig, Germany. In 2014, he has been joined as DST Fast Track Young Scientist at Centre of Biomedical Research (CBMR). He joined as UGC-Assistant professor at UIPS, Panjab University, Chandigarh in April 2018. His research interests lie in the development of new reactions, asymmetric synthesis, enzyme catalysed reactions, development of API, transition metal catalyzed reactions, new synthetic strategies for heterocycles and biologically active molecules and to find out their applications in medicinal chemistry and drug discovery.
Employment
-
Panjab University UGC Assistant Professor2018 - Present
-
CBMR Lucknow DST Fast Track Young Scientist2014 - 2017
-
University of Leipzig Postdoctoral Researcher2012 - 2013
-
University of Antwerp Postdoctoral2010 - 2012
-
Indian Institute of Technology Ext. SRF/ RA2008 - 2010
Education
-
UPTU Ph. D.2004 - 2008
-
Lucknow University M. Sc.1997 - 1999
-
Lucknow University B. Sc.1994 - 1997
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- Design and synthesis of 2-substituted phenyl-4,5-diphenyl imidazole linked benzotriazoles: Anti-breast cancer activity, cell cycle analysis, apoptosis assay, and in silico studies Save
- Design, Synthesis, Biological Evaluation, and In Silico Study of N‐(Pyrazin‐2‐yl)Alkyl/Aryl Amide Derivatives as Quorum Sensing Inhibitors Against Pseudomonas aeruginosa Save
- 4-(Aryl/alkylsulfonamido)-N-(Pyridin-2/3-yl)benzamide derivatives as quorum sensing inhibitors against Pseudomonas aeruginosa: experimental and in-silico studies Save
- CAR-T cell therapy: A therapeutic strategy for cancer treatment Save
- Bacterial biofilm and its role in antibiotic resistance Save
- Design, Synthesis, Biological Evaluation, and In Silico Study of N‐(Pyridin‐2/3‐yl)alkanamide Derivatives as Quorum Sensing Inhibitors Against Pseudomonas aeruginosa Save
- Synthesis, in Silico Study and Biological Evaluation of N‐(Benzothiazol/Thiazol‐2‐yl)benzamide Derivatives as Quorum Sensing Inhibitors against Pseudomonas aeruginosa Save
- Synthesis, Biological Evaluation and in Silico Study of N‐(2‐ and 3‐Pyridinyl)benzamide Derivatives as Quorum Sensing Inhibitors against Pseudomonas aeruginosa Save
- Transition Metal Free α−C−H Functionalization of Six Membered Heteroaromatic‐N‐Oxides Save
- Synthesis and Studies of Thiazolidinedione–Isatin Hybrids As α-Glucosidase Inhibitors for Management of Diabetes Save